Haroun Gajraj: Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, shared a post on LinkedIn:
“Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
That’s not a rare complication.
That’s one in three.
In fact if it occurs in 30% is it really a complication?
Is it a side effect?
Is it an expectation?
For a procedure patients choose to improve their appearance, post-sclerotherapy hyperpigmentation can be more distressing than the original spider veins – and more damaging to your patient relationship.
But can it be mitigated by the consultation process?
The question isn’t whether it happens in your practice.
It’s whether you know WHY it happens – and What to do about it.”
Other posts featuring Haroun Gajraj on Hemostasis Today.
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on Hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?